Orexigen Seeks Toss Of Suit Over Drug Trial Leaks
A lawsuit seeking damages from Orexigen Therapeutics Inc.'s board for sharing confidential information about an unfinished obesity drug trial fails to connect the leaks to any improper intent, a directors' attorney...To view the full article, register now.
Already a subscriber? Click here to view full article